Definitive Contract HHSD200201794416C
Award Date 7/1/17
Potential Completion Date 6/30/18
Potential Value $41M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the supply of adult vaccines. The contract has a ceiling value of $54,499,343.31 and an ultimate completion date of June 30, 2016. The contract does not have a set-aside designation. Pfizer, the prime contractor, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. This contract...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Definitive Contract to Pfizer Inc., a large pharmaceutical company, for the 2017 Vaccines for Children program. The contract has a potential value of $1,347,249,175.05 and a completion date of March 31, 2018. The contract does not have a set-aside designation. Under this award, Pfizer will provide a variety of pharmaceutical products and vaccines to support immunization programs...
- This is a $21,494,073,684.68 Definitive, Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc. (Wyeth Division) for a pediatric vaccine program. The contract has an ultimate completion date of March 31, 2011 and was not set aside. This contract appears to be part of the CDC's Vaccines for Children (VFC) program, which provides vaccines at no cost to children who might not otherwise be vaccinated because of...
- This $2,299,932.44 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the storage and rotation of Pfizer's COVID-19 vaccine. The contract has an ultimate completion date of July 31, 2022 and was awarded on August 1, 2017. The contract does not have a set-aside designation. Pfizer, a large global pharmaceutical corporation, is the prime contractor for this award. The contract is part of a larger Indefinite Delivery Vehicle (IDV) that...
- This is a $8,650,565,549.53 Firm Fixed Price definitive contract awarded to Pfizer Inc. by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for the provision of COVID-19 vaccines. The contract has an ultimate completion date of May 29, 2024 and was awarded on October 1, 2022 without any set-aside designation. Pfizer, a global pharmaceutical manufacturer, is the prime contractor for this award. The contract supports the government's COVID-19 vaccine initiatives and is...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Pfizer Inc., doing business as Pfizer, a $103,298.40 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract. Pfizer will provide COVID-19 (COMIRNATY) vaccines to the CDC from September 22, 2023 through October 31, 2023. The delivery order supports the CDC's ongoing efforts to purchase and distribute COVID-19 vaccines as part of its pandemic response...
- This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
- This is a $29,475,985.60 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the provision of various adult vaccines. The contract has a period of performance from July 1, 2015, to June 30, 2016, and is a firm fixed-price contract. Merck is a large pharmaceutical manufacturer that has been a critical partner in supplying essential vaccines and pharmaceutical products to support federal healthcare...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,085,922,457.04 firm fixed price contract to Glaxosmithkline, LLC for the provision of vaccines for children. The contract, which did not have a set-aside designation, has a performance period ending on March 31, 2018. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines, antivirals, and other pharmaceutical products to federal agencies including the...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...